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designated proliferin. MRP is not produced by primary mouse embryo fibroblasts to nearly the same extent as
it is produced by many immortal or transformed lines. Control of expression of this protein by growth factors
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Mitogen-regulated protein (MRP) is secreted by certain immortal murine cell lines (Swiss 3T3, BNL)
stimulated with serum or particular growth factors. We have identified a cDNA clone that encodes part of the
protein and have confirmed that MRP is closely related to, if not identical to, the prolactin-related protein
designated proliferin. MRP is not produced by primary mouse embryo fibroblasts to nearly the same extent as
it is produced by many immortal or transformed lines. Control of expression of this protein by growth factors
is achieved both by regulating the extent of transcription and by regulating the processing of the protein.
Mitogen-regulated protein (MRP) was described by
Nilsen-Hamilton et al. (12) as a [35S]methionine-labeled
family of glycoproteins (Mr, 30,000 to 38,000) released by
Swiss mouse 3T3 cells some 18 to 28 h after stimulation with
growth factors (serum, fibroblast growth factor, epidermal
growth factor); platelet-derived growth factor and the tumor
promoter 12-tetra-decanoylphorbol-13-acetate were shown
subsequently to be effective at stimulating release also.
Evidence for glycosylation includes the facts that treatment
with endoglycosidase H reduces the apparent molecular
weight substantially and that the protein synthesized in the
presence of tunicamycin has a lower Mr of about 22,000. An
antiserum raised against purified MRP has been used to
identify the protein unambiguously.
Not only mitogens, but also substances that increase
intralysosomal pH (NH4CI, chloroquine, and the ionophores
monensin and nigericin) enhance the production of MRP
(14). This suggests that MRP levels are, in part, regulated at
the level of protein degradation, since these latter substances
inhibit degradation of lysosomal proteins. In agreement with
this is the observation that the ionophore-stimulated release
of MRP is not blocked by actinomycin D, in contrast to
growth factor-induced release (M. Nilsen-Hamilton and
R. T. Hamilton, unpublished data). Proteins known to be
secreted by fibroblasts include plasminogen activator, colla-
genase, fibronectin, procollagen, and major excreted protein
(13). Proteins for which there is evidence (in other cell types)
that the secreted quantities are regulated by intracellular
degradation include prolactin, parathormone, and pro-
collagen (2).
We have used an antiserum raised against MRP (R. T.
Hamilton and M. Nilsen-Hamilton unpublished data) to
screen a Xgtll expression library (18) for clones able to code
for one or more epitopes found on MRP. Mouse BNL cells
(15) were used as the source of poly(A) mRNA for cloning,
since among the cell lines tested it produced the most MRP.
* Corresponding author.
To provide initial enrichment for poly(A) mRNA molecules
coding for MRP, the cytoplasmic poly(A) mRNA extracted
from a growing population of mouse BNL cells was fraction-
ated by velocity sedimentation in a sucrose gradient contain-
ing formamide. We recovered the RNA in separate pools and
examined it by in vitro translation and immunoprecipitation
to identify the fraction most enriched for MRP mRNA. The
cDNA synthesized from that fraction by the method of Land
et al. (6) was used to construct a AgtlO library (XgtlO
provided by T. Huynh and R. Davis, Stanford University).
The inserts were subsequently subcloned into Xgtll. Ap-
proximately 5 x 104 recombinant Xgtll plaques were
screened with anti-MRP antibody, and positive plaques were
identified at a frequency of one in 5,000. Three positive
plaques were chosen for DNA preparation and EcoRI re-
striction; each of these presumptive Agtll MRP clones
contained an insert of approximately 230 base pairs.
In vitro translation of hybrid-selected mRNA was used to
verify the identity of two putative MRP clones and to
discriminate against the possibility that the cDNA clones
recovered by the immunoscreening procedure coded for an
unrelated, but cross-reacting, peptide. Preimmune serum did
not produce a positive reaction. Hybrid-selected (11), com-
plementary mRNA was translated in a reticulocyte lysate;
the resulting [35S]methionine-labeled proteins were analyzed
by sodium dodecyl sulfate-polyacrylamide gel electrophore-
sis (5). A single major translation product was selectively
enriched after hybridization of mRNA to the two MRP
cDNA clones immobilized on aminophenylthioether paper,
and immunoprecipitation of these translation products with
anti-MRP confirmed that the major translation product (Mr,
26,000) was recognized by the antiserum (Fig. 1).
The nucleotide sequence obtained for one MRP cDNA
clone contained a single open reading frame spanning the
entire 226-base-pair insert. Comparison of this sequence
with that determined for the protein-coding region of
proliferin, a serum-induced mRNA of BALB/c 3T3 cells (8,
9), revealed an exact match with nucleotide residues 379 to
604 of the corresponding cDNA clone PLF-1. The region of
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FIG. 1. Hybrid selection and in vitro translation of MRP mRNA.
Shown is a fluorograph of a sodium dodecyl sulfate-polyacrylamide
gel of the [35S]methionine-labeled proteins produced by translation
of BNL mRNA in a reticulocyte lysate. (a) Lanes: 1, total BNL
mRNA; M, molecular weight markers. (b) Hybrid selection of MRP
mRNA with MRP cDNA clones. Two separate MRP cDNA clones
that had been identified in the antibody screening step were
subcloned into M13mp8. Viral replicative form DNA was isolated,
denatured, and fixed to aminophenylthioether paper (11). Lanes: 1
and 2, MRP cDNA clones; 3, M13mp8 replicative form DNA. (c)
Immunoprecipitation (16) of products translated from the hybrid-
selected mRNA shown in b.
overlap represents an area toward the carboxyl terminus of
the peptide. This identity confirms the conclusion reached
earlier on the basis of a positive antibody reaction with
anti-MRP and proliferin protein generated from a eucaryotic
expression vector containing the cloned proliferin cDNA
(M. Nilsen-Hamilton, R. T. Hamilton, and S. Lee, manu-
script in preparation).
Previous observations on the amounts of secreted MRP
have revealed that Swiss 3T3 (17) and BALB/c 3T3 (1) cell
lines respond differently to the addition of growth factors to
the conditioned medium of growing cells. In contrast to
BALB/c 3T3 and SV40-transformed Swiss 3T3 cells, addi-
tion of fibroblast growth factor to Swiss 3T3 cells stimulated
them to synthesize and secrete MRP (14). To assess rela-
tionships between cytoplasmic MRP mRNA content and the
ability or inability to secrete MRP, we compared several
permanent mouse cell lines by Northern gel analysis, as
described elsewhere (4; D. R. Edwards, C. L. J. Parfett, and
D. T. Denhardt, Mol. Cell. Biol., in press), by using the
226-base-pair cDNA clone as a probe. Poly(A) mRNA from
cultures growing in medium containing 10% fetal bovine
serum (FBS) gave strong autoradiographic signals (Fig. 2a).
The two Swiss 3T3 lines (ATCC CCL92 and CLL173)
contained the greatest relative levels of MRP mRNA,
whereas the two BALB/c 3T3 lines (ATCC CCL163 and
CCL163.1) and the BNL line contained lesser amounts. The
JB6 epidermal line (3) had no detectable MRP mRNA (data
not shown). In a second experiment, in which we prepared
mRNA from growing BNL, Swiss 3T3, and BALB/c 3T3
cells 20 h after replacing the culture medium with fresh
medium plus 10% FBS, the levels of MRP mRNA were
nearly identical in all three cell lines, suggesting that growth
conditions may affect the abundance of this transcript (Fig.
2b).
Serum induction of MRP mRNA was observed when
quiescent Swiss 3T3 cells maintained in medium containing
0.5% serum were stimulated with medium containing 10%
FBS. A 1-kilobase poly(A) mRNA that was undetectable in
quiescent cells rose to substantially higher levels by 18 h
after stimulation (Fig. 3a), as has been documented for
proliferin in BALB/c 3T3 cells. Some message migrating
slightly faster on the Northern gels could be detected in the
fractions of RNA enriched in poly(A)-deficient RNA, and
this species also was increased at 12 and 18 h after stimula-
tion (Fig. 3b). The induction of MRP mRNA after 6 h of
incubation in 10% FBS could be prevented by adding either
of the two transcription inhibitors actinomycin D or 5,6-
dichloro-1-3-D-ribofuranosylbenzimidazole, suggesting that
the observed increase in cytoplasmic MRP mRNA was
under transcriptional control (Fig. 3c).
To extend our observations on the regulation of MRP gene
expression to normal mouse cells, we also examined the
induction of MRP mRNA after serum stimulation of quies-
cent secondary mouse embryo fibroblast (MEF) cultures
prepared from 14- to 16-day-old embryos as described pre-
viously (4). Fig. 3a also shows the hybridization signals
obtained with a control cDNA clone (pLP1) corresponding
to an mRNA species whose abundance was constant in both
MEFs and 3T3 cells regardless of the growth state of the
cells. Only trace amounts of MRP mRNA could be detected
in MEFs up to 28 h after refeeding with 10% FBS-containing
medium (Fig. 3a). DNA synthesis began at about 12 h after
serum addition (data not shown). Other mRNA species
known to be induced by serum were readily observed to
increase over this period with the same RNA preparations
(Edwards et al., in press). Thus, failure to detect significant
enrichment of MRP mRNA in cytoplasmic poly(A) mRNA
after serum stimulation does not reflect general unrespon-
siveness in MEFs at the level of mRNA transcription or
processing. Higher concentrations (20%) of serum were also
unable to induce MRP transcription (data not shown).
Our demonstration that (i) there was complete sequence
identity over the region shared by the MRP and proliferin
cDNA clones, (ii) both hybridized to an mRNA approxi-
mately 1 kilobase in size, and (iii) the MRP mRNA was
induced in response to serum stimulation of quiescent cells
in culture supports the conclusion (Nilsen-Hamilton et al., in
preparation) that mitogen-regulated protein and proliferin
are one and the same.
Comparison of the levels of poly(A) mRNA within a group
of six permanent cell lines and a culture of normal mouse
embryo cells suggested two points of regulation. Cytoplas-
mic accumulation of mRNA was very dependent on condi-
tions among the immortal cells studied, indicating that
transcription and processing of the message are likely points
for regulatory controls. This conclusion was supported in a
study of transcriptional regulation of serum-induced RNAs
from Swiss 3T3 fibroblasts in which both the level of MRP
mRNA within the nucleus (Edwards et al., in press) and the
amount of nuclear runoff transcription increased after serum
stimulation of Swiss 3T3 cells (D. R. Edwards, unpublished
observation). Furthermore, the induction of MRP mRNA
and cellular proliferative responses are separable, since this
species was undetectable in the cytoplasm of serum-
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stimulated normal mouse embryo cells under conditions in
which DNA synthesis and cell division occurred; also, no
MRP mRNA could be detected in JB6 cells growing in 10%
FBS.
Although MRP mRNA was inducible in both Swiss 3T3
and BALB/c 3T3 mouse cells, the protein was not detected
in BALB/c 3T3 cells after stimulation by calf serum or
purified growth factors (12, 14), pointing to possible transla-
tional or postranslational regulatory mechanisms that oper-
ate differently in these cell lines. In this regard it has been
shown that lysosomal degradation of newly synthesized
MRP plays a major role in determining the quantity of MRP
secreted by Swiss 3T3 cells into the culture medium (14;
Nilsen-Hamilton et al., submitted for publication).
It is interesting that cell lines expressing the MRP gene(s)
predominate among those so far examined (BNL; NIH 3T3,
3T6, and Ehrlich ascites cells are especially good). We have
observed this mRNA in five of six independent cell lines,
whereas Linzer and Nathans (10) reported proliferin mRNA
in C3H 1OT1/2 and Krebs ascites carcinoma cells. These
observations raise the possibility that mitogen-inducible
expression of MRP could serve as a molecular marker for
many of the cells selected to exhibit permanent growth in
vitro. Absence of detectable MRP transcripts in JB6 cells
indicates that MRP is not obligatorily involved in the estab-
lishment phenomenon. Investigations of the tissue speci-
ficity of MRP (proliferin) synthesis in the mouse (7) and the
factors responsible for regulating its expression in vivo may
provide clues to the origin of MRP expression in cell lines.
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FIG. 2. MRP mRNA content of mouse cell lines. (a) Glyoxal-
denatured poly(A) mRNA (4 jig in each lane) extracted from
subconfluent, growing cultures of each cell line was separated by
electrophoresis in 1.0% agarose and transferred to nitrocellulose.
The blot was hybridized with nick-translated, denatured MRP-
M13mp8 double-stranded DNA as the probe. (b) Total cytoplasmic
RNA (20 jg in each lane) was isolated from subconfluent, growing
cultures 20 h after a change to fresh culture medium supplemented
with 10% FBS. The RNA was electrophoresed in a 1.1% agarose gel
in 2.2 M formaldehyde (11) and then blotted and probed as in a. The
size markers were produced by HaeIlI and TaqI restriction of
M13mp8 and M13mp7 DNAs, respectively. Numbers on the right
indicate the lengths, in nucleotides, of marker single-stranded
oligodeoxynucleotides.
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FIG. 3. Serum induction of MRP mRNA in Swiss 3T3 cells and
secondary MEFs. Electrophoresis, blotting, and hybridization were
the same as in Fig. 2b. (a) Poly(A) mRNA was isolated from cells at
the indicated times after stimulation of quiescent cells with medium
containing 10%'o serum. Swiss 3T3 cells and MEFs were made
quiescent by growth for several days in medium containing 0.5 and
2% serum, respectively. Four micrograms of each poly(A) mRNA
preparation was used per lane. The blot was also hybridized with a
probe derived from a control clone (pLP1) that corresponded to an
mRNA of approximately 700 nucleotides, whose abundance is
invariant in cultured MEFs and 3T3 cells. (b) Swiss 3T3 poly(A)-
deficient RNA (20 jig) (i.e., RNA that failed to bind to oligo(dT)-
cellulose in a single binding-elution step) from cells at the same time
points as in a was applied to each lane. (c) Total cytoplasmic RNA
(20 jig) from Swiss 3T3 cells at various times after serum stimulation
and after 6 h with (i) 10% serum plus 25 ,ug of 5,6-dichloro-1-0-D-
ribofuranosylbenzimidazole (DRB; Calbiochem-Behring, LaJolla,
Calif.) per ml or (ii) 10% serum plus 2 ,ug of actinomycin D (Act D)
per ml.
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